Monday, November 9, 2026

USD/EUR Rises By 3% In The Last 21 Sessions

ViaNews Editorial Team

November 10, 2023

USD/EUR Rises By 3% In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 3.06% for the last 21 sessions. At 06:09 EST on Friday, 10 November, USD/EUR (USDEUR) is $0.94.

USD/EUR's yearly highs and lows, it's 5.615% up from its 52-week low and 4.778% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.21%, a negative 0.05%, and a positive 0.29%, respectively.

USD/EUR's highest amplitude of average volatility was 0.38% (last week), 0.31% (last month), and 0.29% (last quarter), respectively.

News about

  • According to FXStreet on Wednesday, 8 November, "At the time of writing, the EUR/USD pair is trading at 1.0665, down 0.29% on the day"
  • Eur/usd forex signal: falling on stronger dollar - 08 November 2023. According to DailyForex on Wednesday, 8 November, "My previous EUR/USD signal on 23rd October was not triggered as there were no reversals when any of the key support or resistance levels were first reached.", "In my previous analysis of the EUR/USD currency pair, I wrote that we were likely to see a continuing consolidation today, meaning that all the support and resistance levels were quite likely to hold. "
  • Eur/usd: fresh 2023 lows prior to year-end – CIBC. According to FXStreet on Wednesday, 8 November, "With significant negativity already priced for Europe, further EUR/USD weakness will come from the USD leg, economists at CIBC Capital Markets report.", "Although real money players may have almost halved EUR holdings from early August highs a further consolidation underlines the presumption of fresh 2023 EUR/USD lows prior to year-end."
  • Eur/usd: things might get volatile today – commerzbank. According to FXStreet on Wednesday, 8 November, "That means that despite a lack of data in EUR/USD things might get volatile today. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com